Company profile for Zogenix

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Zogenix is committed to developing and commercializing transformative therapies to improve the lives of patients and their families living with rare diseases. Zogenix is a growing U.S.-based pharmaceutical company passionate about taking on the complex challenges of developing therapeutic solutions with the potential to transform the lives of rare disease patients and their families. To learn more about the company’s curr...
Zogenix is committed to developing and commercializing transformative therapies to improve the lives of patients and their families living with rare diseases. Zogenix is a growing U.S.-based pharmaceutical company passionate about taking on the complex challenges of developing therapeutic solutions with the potential to transform the lives of rare disease patients and their families. To learn more about the company’s current development projects, click here.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
5858 Horton Street Suite 455 Emeryville, California 94608
Telephone
Telephone
1-858-259-1165
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercepharma.com/marketing/ucb-bangs-drum-epilepsy-drug-videos-about-sound-profound-seizure-reduction

FIERCE PHARMA
19 Jun 2024

https://pharmaphorum.com/news/ucb-takes-on-jazz-in-severe-epilepsy-with-new-fintepla-approval/

E. Sagonowsky PHARMAPHORUM
29 Mar 2022

https://www.globenewswire.com/news-release/2022/03/04/2397124/0/en/Zogenix-To-Present-New-Long-term-Data-on-FINTEPLA-fenfluramine-in-Lennox-Gastaut-Syndrome-LGS-at-AAN-2022.html

GLOBENEWSWIRE
04 Mar 2022

https://www.globenewswire.com/news-release/2022/02/28/2393133/0/en/Zogenix-Provides-Corporate-Update-and-Reports-Fourth-Quarter-and-Full-Year-2021-Financial-Results.html

GLOBENEWSWIRE
28 Feb 2022

https://endpts.com/zogenix-pulls-controversial-opioid-zohydro-er-from-the-market-ahead-of-ucb-acquisition/

Z. Brennan ENDPTS
02 Feb 2022

https://www.biopharmadive.com/news/ucb-zogenix-acquire-deal-epilepsy-drug/617337/

B. Fidler BIOPHARMADIVE
20 Jan 2022

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty